Full-Time

QC Analyst II

Posted on 1/15/2025

Zoetis

Zoetis

5,001-10,000 employees

No salary listed

Junior, Mid

Kalamazoo, MI, USA

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Required Skills
SAP Products
Requirements
  • AAS, BA/BS, or MS in Chemistry, Biochemistry, or related science preferred
  • Related experience in Quality Control is preferred but not required
  • Preferred experience includes GMP documentation, drug product formulation, in-plant laboratory, Incoming Inspection, SAP, LIMS, HPLC, Dissolution, use of Empower3
  • Candidate must not be Cephalosporin/Penicillin sensitive
Responsibilities
  • Performs, documents and record checks qualitative and quantitative assays on samples
  • Interprets and evaluates data for accuracy, precision, trends, and potential GMP impact
  • Recommends and executes process improvements to continually improve laboratory performance
  • Demonstrates flexibility/agility and engagement in a changing environment
  • May train others as skills and knowledge allow
  • Troubleshoot instrumentation as skills and knowledge allow
  • Participates in laboratory investigations as required
  • May participate in manufacturing QC support such as cleaning verification
Desired Qualifications
  • Related experience in Quality Control is preferred but not required
  • Key characteristics of a successful candidate in this position: willingness and ability to learn, ability to work in a team environment, and attention to detail

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Parsippany-Troy Hills, New Jersey

Founded

1952

Simplify Jobs

Simplify's Take

What believers are saying

  • Zoetis benefits from the growing pet insurance market, boosting demand for veterinary products.
  • The animal health market is projected to reach $112.33 billion by 2030, offering growth opportunities.
  • Zoetis' focus on digital health solutions aligns with industry trends towards remote diagnostics.

What critics are saying

  • Emerging biotech firms in animal health pose competitive threats to Zoetis' market share.
  • Departure of key legal personnel may lead to challenges in legal and compliance areas.
  • Potential overvaluation concerns could lead to stock volatility for Zoetis.

What makes Zoetis unique

  • Zoetis is the world's leading animal health company, showcasing strong market leadership.
  • The company launched Vetscan OptiCell, a screenless hematology analyzer, enhancing diagnostic capabilities.
  • Zoetis' strategic growth initiatives were highlighted at the J.P. Morgan Healthcare Conference.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Company News

MarketBeat
Mar 11th, 2025
Clare Market Investments LLC Makes New $670,000 Investment in Zoetis Inc. (NYSE:ZTS)

Clare Market Investments LLC makes new $670,000 investment in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Mar 10th, 2025
Raymond James Financial Inc. Makes New $196.65 Million Investment in Zoetis Inc. (NYSE:ZTS)

Raymond James Financial Inc. makes new $196.65 million investment in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Feb 27th, 2025
World Equity Group Inc. Invests $342,000 in Zoetis Inc. (NYSE:ZTS)

World Equity Group Inc. invests $342,000 in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Feb 22nd, 2025
Tandem Investment Advisors Inc. Invests $32.19 Million in Zoetis Inc. (NYSE:ZTS)

Tandem Investment Advisors Inc. invests $32.19 million in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Jan 17th, 2025
Miracle Mile Advisors LLC Makes New $272,000 Investment in Zoetis Inc. (NYSE:ZTS)

Miracle Mile Advisors LLC makes new $272,000 investment in Zoetis Inc. (NYSE:ZTS).

INACTIVE